Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

Compare more Oncology professors.

h-index111
i10-index484
Publications1,980
Citations59,037

Grants

11 total · 2 active

NIH #K12CA088084

Paul Calabresi Clinical Oncology Award

Active
Amount
$800K–$900K
Period
2000-09-13 → 2027-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA262805

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$700K–$800K
Period
2022-04-01 → 2027-03-31
PIs
2

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #P30CA016672

07 Gastrointestinal Cancers

Amount
<$100K
Period
1996-08-28 → 2026-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

11 total · 2 active

NIH #K12CA088084

Paul Calabresi Clinical Oncology Award

Active
Amount
$800K–$900K
Period
2000-09-13 → 2027-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA262805

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Active
Amount
$700K–$800K
Period
2022-04-01 → 2027-03-31
PIs
2

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #P30CA016672

07 Gastrointestinal Cancers

Amount
<$100K
Period
1996-08-28 → 2026-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #UH3CA207101

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$300K–$400K
Period
2018-09-21 → 2024-08-31
PIs
4

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #P50CA221707

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

Amount
$2M–$3M
Period
2019-08-20 → 2024-05-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #U24CA220325

MDACC-PREDICT

Amount
$600K–$700K
Period
2020-09-01 → 2023-08-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA218230

Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies

Amount
$600K–$700K
Period
2018-07-01 → 2023-06-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #U54CA224065

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

Amount
$200K–$300K
Period
2017-09-30 → 2022-08-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA184843

Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition

Amount
$600K–$700K
Period
2015-02-13 → 2021-01-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #UH2CA207101

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$200K–$300K
Period
2018-09-21 → 2020-08-31
PIs
4

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA187238

Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer

Amount
$300K–$400K
Period
2014-08-04 → 2020-07-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Recent Public Signals

  1. New paper: Spatial multi-omics landscape of colorectal cancer macro- and micrometastases (Cancer Cell)2026-07-01
  2. New NIH award: Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer2022-04-01
  3. New NIH award: Paul Calabresi Clinical Oncology Award2000-09-13

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-9647-3416

Professor Insights

Career Trajectory